Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension

Abstract Background Idiopathic intracranial hypertension (IIH) is a disorder of unidentified etiology characterized by raised intracranial pressure (ICP) without clinical, laboratory, or radiological evidence of intracranial pathology. The aim of this work was to determine the visual outcome in newl...

Full description

Bibliographic Details
Main Authors: Wafik Said Bahnasy, Yasser Abo Elfotoh El-Heneedy, Mahmoud Ebrahim Mostafa Elhassanien, Amr Fawzy Sharaf, Hagar Ahmed Khalid
Format: Article
Language:English
Published: SpringerOpen 2019-05-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41983-019-0081-z
_version_ 1818505911199596544
author Wafik Said Bahnasy
Yasser Abo Elfotoh El-Heneedy
Mahmoud Ebrahim Mostafa Elhassanien
Amr Fawzy Sharaf
Hagar Ahmed Khalid
author_facet Wafik Said Bahnasy
Yasser Abo Elfotoh El-Heneedy
Mahmoud Ebrahim Mostafa Elhassanien
Amr Fawzy Sharaf
Hagar Ahmed Khalid
author_sort Wafik Said Bahnasy
collection DOAJ
description Abstract Background Idiopathic intracranial hypertension (IIH) is a disorder of unidentified etiology characterized by raised intracranial pressure (ICP) without clinical, laboratory, or radiological evidence of intracranial pathology. The aim of this work was to determine the visual outcome in newly diagnosed IIH patients. Methods The study included 68 IIH patients; 59 responded to medical treatment and nine needed lumboperitoneal shunting (LPS). Patients were submitted to papilledema grading using Frisén Scale, water CSF manometry, brain MRI/MRV, mean deviation of visual field examination (MD-VFE), optic nerve sheath diameter (ONSD), average optic disc optical coherence tomography–retinal nerve fiber layer (OCT–RNFL) thickness, and pattern–reversal visual evoked potential (VEP). Results Patients needed LPS showed statistically significant increase in baseline papilledema grade, MD-VFE, ONSD, average OCT–RNFL thickness, and P100 VEP latency. On the other hand, both studied groups showed statistically non-significant differences regarding the patients’ ages and opening CSF pressure. Conclusion Newly diagnosed IIH patients’ evaluation must be based on multimodality neuro-ophthalmological assessment where papilledema grade, MD-VFE, and OCT–RNFL are valuable biomarkers of PVD while P100 VEP latency delay is a predictor of poor visual outcome and ONSD is an early indicator of elevated ICP regression after LPS surgery.
first_indexed 2024-12-10T21:57:18Z
format Article
id doaj.art-350a25b7f1084a58a42571d2208aa21d
institution Directory Open Access Journal
issn 1687-8329
language English
last_indexed 2024-12-10T21:57:18Z
publishDate 2019-05-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
spelling doaj.art-350a25b7f1084a58a42571d2208aa21d2022-12-22T01:32:00ZengSpringerOpenThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery1687-83292019-05-015511810.1186/s41983-019-0081-zNeuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertensionWafik Said Bahnasy0Yasser Abo Elfotoh El-Heneedy1Mahmoud Ebrahim Mostafa Elhassanien2Amr Fawzy Sharaf3Hagar Ahmed Khalid4Department of Neuropsychiatry, Faculty of Medicine, Tanta UniversityDepartment of Neuropsychiatry, Faculty of Medicine, Tanta UniversityDepartment of Neuropsychiatry, Faculty of Medicine, Tanta UniversityDepartment of Neuropsychiatry, Faculty of Medicine, Tanta UniversityDepartment of Neuropsychiatry, Faculty of Medicine, Tanta UniversityAbstract Background Idiopathic intracranial hypertension (IIH) is a disorder of unidentified etiology characterized by raised intracranial pressure (ICP) without clinical, laboratory, or radiological evidence of intracranial pathology. The aim of this work was to determine the visual outcome in newly diagnosed IIH patients. Methods The study included 68 IIH patients; 59 responded to medical treatment and nine needed lumboperitoneal shunting (LPS). Patients were submitted to papilledema grading using Frisén Scale, water CSF manometry, brain MRI/MRV, mean deviation of visual field examination (MD-VFE), optic nerve sheath diameter (ONSD), average optic disc optical coherence tomography–retinal nerve fiber layer (OCT–RNFL) thickness, and pattern–reversal visual evoked potential (VEP). Results Patients needed LPS showed statistically significant increase in baseline papilledema grade, MD-VFE, ONSD, average OCT–RNFL thickness, and P100 VEP latency. On the other hand, both studied groups showed statistically non-significant differences regarding the patients’ ages and opening CSF pressure. Conclusion Newly diagnosed IIH patients’ evaluation must be based on multimodality neuro-ophthalmological assessment where papilledema grade, MD-VFE, and OCT–RNFL are valuable biomarkers of PVD while P100 VEP latency delay is a predictor of poor visual outcome and ONSD is an early indicator of elevated ICP regression after LPS surgery.http://link.springer.com/article/10.1186/s41983-019-0081-zIdiopathic intracranial hypertensionPapilledemaAutomated perimetryOptic nerve sheath diameterOptical coherence tomographyVisual evoked potential
spellingShingle Wafik Said Bahnasy
Yasser Abo Elfotoh El-Heneedy
Mahmoud Ebrahim Mostafa Elhassanien
Amr Fawzy Sharaf
Hagar Ahmed Khalid
Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Idiopathic intracranial hypertension
Papilledema
Automated perimetry
Optic nerve sheath diameter
Optical coherence tomography
Visual evoked potential
title Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension
title_full Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension
title_fullStr Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension
title_full_unstemmed Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension
title_short Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension
title_sort neuro ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension
topic Idiopathic intracranial hypertension
Papilledema
Automated perimetry
Optic nerve sheath diameter
Optical coherence tomography
Visual evoked potential
url http://link.springer.com/article/10.1186/s41983-019-0081-z
work_keys_str_mv AT wafiksaidbahnasy neuroophthalmologicalbiomarkersofvisualoutcomeinnewlydiagnosedidiopathicintracranialhypertension
AT yasseraboelfotohelheneedy neuroophthalmologicalbiomarkersofvisualoutcomeinnewlydiagnosedidiopathicintracranialhypertension
AT mahmoudebrahimmostafaelhassanien neuroophthalmologicalbiomarkersofvisualoutcomeinnewlydiagnosedidiopathicintracranialhypertension
AT amrfawzysharaf neuroophthalmologicalbiomarkersofvisualoutcomeinnewlydiagnosedidiopathicintracranialhypertension
AT hagarahmedkhalid neuroophthalmologicalbiomarkersofvisualoutcomeinnewlydiagnosedidiopathicintracranialhypertension